Brenner Erin K. 4
4 · Pear Therapeutics, Inc. · Filed Jan 18, 2023
Insider Transaction Report
Form 4
Brenner Erin K.
Chief Product Dev. Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-01-14−22,000→ 44,667 total→ Common Stock (22,000 underlying) - Exercise/Conversion
Common Stock
2023-01-14+22,000→ 52,000 total
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of PEAR common stock.
- [F2]The remaining restricted stock units shall vest and settle as to 33% of the shares on January 14, 2024 and 34% on January 14, 2025.